| FDA warns against using kratom for opioid addiction | | | (Reuters) - The U.S. Food and Drug Administration on Tuesday waded once again into the hotly contested debate over the safety of kratom, a botanical substance that advocates say can help ease pain and reduce symptoms of opioid withdrawal, but which critics say can lead to addiction and death. |
| |
| Investor group warns U.S. farm antibiotic policy lagging | | | LOS ANGELES (Reuters) - The United States is falling behind Europe in the fight to curb the overuse and misuse of antibiotics in meat production and experts are warning of the possibility of dangerous drug-resistant "superbug" infections as a result, according to a new report on Tuesday. |
| |
| Eighth New Zealand farm tests positive for cattle disease | | | WELLINGTON (Reuters) - New Zealand's Primary Industries ministry said on Wednesday that an eighth farm in the country's South Island has tested positive for the cattle disease mycoplasma bovis, which can seriously affect animal health. |
| |
| Loxo signs lucrative cancer drug deal with Bayer, but shares fall | | | (Reuters) - Loxo Oncology on Tuesday signed a collaboration agreement for its promising cancer drugs with Germany's Bayer AG that could be worth up to $1.55 billion to the tiny U.S. company, but its shares fell 11 percent as the deal appeared to end near-term likelihood of a takeover. |
| |
| U.S. top court to hear fight over California pregnancy center law | | | WASHINGTON (Reuters) - The U.S. Supreme Court on Monday agreed to decide whether a California law requiring private facilities that counsel pregnant women against abortion to post signs telling clients how to get state-funded abortions and contraceptives violates free speech rights. |
| |
| Biotech firms race to recruit good bugs in war on cancer | | | (Reuters) - Biotech companies are competing to develop medicines using "bugs as drugs" to fight cancer, building on the latest scientific findings that patients with high levels of good gut bacteria are more likely to respond to modern immunotherapy. |
| |
| | |
